Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Prolidase Activity in Primary Ovarian Insufficiency

NCT05443282 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT05443282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05443282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Prolidase Activity in Primary Ovarian Insufficiency
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
August 10, 2021
Completion date
March 7, 2022
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian failure, premature, ovarian insufficiency, primary, oxidative stress